Pharmacokinetics of dronedarone in rat using a newly developed high-performance liquid chromatographic assay method

A 73-Year-Old Man with Interstitial Lung Disease Due to Dronedarone

(2013) Ana R. Hernández Voth et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Fatal Lung Toxic Effects Related to Dronedarone Use

(2012) Chung-Wah Siu   ARCHIVES OF INTERNAL MEDICINE

Dronedarone Use and Fatal Lung Toxic Effects?

(2012) Nora Goldschlager   ARCHIVES OF INTERNAL MEDICINE

Drug safety evaluation of dronedarone in atrial fibrillation

(2012) Gaetano M De Ferrari et al.   Expert Opinion On Drug Safety

Mechanisms of Hepatocellular Toxicity Associated with Dronedarone—A Comparison to Amiodarone

(2012) Andrea Felser et al.   TOXICOLOGICAL SCIENCES

Simultaneous determination of dronedarone and its active metabolite debutyldronedarone in human plasma by liquid chromatography–tandem mass spectrometry: Application to a pharmacokinetic study

(2011) Cen Xie et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

Dronedarone as a new treatment option for atrial fibrillation patients: pharmacokinetics, pharmacodynamics and clinical practice

(2010) Burak Pamukcu et al.   EXPERT OPINION ON PHARMACOTHERAPY

Clinical Pharmacology of Dronedarone: Implications for the Therapy of Atrial Fibrillation

(2010) Paul Dorian   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS

High performance liquid chromatographic assay for the simultaneous determination of midazolam and ketoconazole in plasma

(2010) Dalia A. Hamdy et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Determination of the class III antiarrhythmic drugs dronedarone and amiodarone, and their principal metabolites in plasma and myocardium by high-performance liquid chromatography and UV-detection

(2009) Robert W. Bolderman et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES